Bin Meng
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- Viral-associated cancers and disorders 6
- CAR-T cell therapy research 5
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 21
- Hepatology top 10%
-
- Immune Cell Function and Interaction 6
-
- Chronic Lymphocytic Leukemia Research 10
-
- Ovarian cancer diagnosis and treatment 6
-
- Esophageal Cancer Research and Treatment 4
- Journals
- Hematological Oncology (4 papers)British Journal of Haematology (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Bin Meng
57 papers receiving 805 citations
Peers
Comparison fields: 5 of 73
- Oncology 334
- Cancer Research 141
- Pathology and Forensic Medicine 151
- Hepatology 53
- Immunology 136
Countries citing papers authored by Bin Meng
This map shows the geographic impact of Bin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Meng more than expected).
Fields of papers citing papers by Bin Meng
This network shows the impact of papers produced by Bin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Meng. The network helps show where Bin Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 11 | |
| 15 | 2020 | 21 | |
| 16 | 2020 | 13 | |
| 17 | 2019 | 27 | |
| 18 | 2018 | 15 | |
| 19 | 2017 | 22 | |
| 20 | 2009 | 2 |
About Bin Meng
Bin Meng is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 62 papers that have together received 814 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Viral-associated cancers and disorders (6 papers), Ovarian cancer diagnosis and treatment (6 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Oncology (334 citations), Cancer Research (141 citations) and Pathology and Forensic Medicine (151 citations). Bin Meng has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Huilai Zhang, Lanfang Li, Lihua Qiu, Shiyong Zhou, Xianhuo Wang, Xiubao Ren, Lingyi Chi, Shugan Zhu, Jian Zhang and C. Liu. Their work appears in journals such as Hematological Oncology, British Journal of Haematology, Oncotarget, Frontiers in Oncology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.